Cargando…
Brain “fog,” inflammation and obesity: key aspects of neuropsychiatric disorders improved by luteolin
Brain “fog” is a constellation of symptoms that include reduced cognition, inability to concentrate and multitask, as well as loss of short and long term memory. Brain “fog” characterizes patients with autism spectrum disorders (ASDs), celiac disease, chronic fatigue syndrome, fibromyalgia, mastocyt...
Autores principales: | Theoharides, Theoharis C., Stewart, Julia M., Hatziagelaki, Erifili, Kolaitis, Gerasimos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490655/ https://www.ncbi.nlm.nih.gov/pubmed/26190965 http://dx.doi.org/10.3389/fnins.2015.00225 |
Ejemplares similares
-
Luteolin as a therapeutic option for multiple sclerosis
por: Theoharides, Theoharis C
Publicado: (2009) -
Corticotropin-releasing hormone and extracellular mitochondria augment IgE-stimulated human mast-cell vascular endothelial growth factor release, which is inhibited by luteolin
por: Asadi, Shahrzad, et al.
Publicado: (2012) -
Neuro-inflammation, blood-brain barrier, seizures and autism
por: Theoharides, Theoharis C, et al.
Publicado: (2011) -
Focal brain inflammation and autism
por: Theoharides, Theoharis C, et al.
Publicado: (2013) -
Luteolin Inhibits Human Keratinocyte Activation and Decreases NF-κB Induction That Is Increased in Psoriatic Skin
por: Weng, Zuyi, et al.
Publicado: (2014)